GRPM vs. CNCR ETF Comparison
Comparison of Invesco S&P MidCap 400? GARP ETF (GRPM) to Loncar Cancer Immunotherapy ETF (CNCR)
GRPM
Invesco S&P MidCap 400? GARP ETF
GRPM Description
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is designed to track the performance of the top 60 growth stocks in the S&P MidCap 400® Index with relatively high quality and value composite scores, which are computed pursuant to the index methodology.
Grade (RS Rating)
Last Trade
$112.72
Average Daily Volume
37,662
Number of Holdings
*
10
* may have additional holdings in another (foreign) market
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$14.92
Average Daily Volume
7,991
Number of Holdings
*
68
* may have additional holdings in another (foreign) market
Performance
Period | GRPM | CNCR |
---|---|---|
30 Days | 4.06% | 13.89% |
60 Days | -0.07% | 2.90% |
90 Days | 2.60% | -5.93% |
12 Months | 18.79% |
0 Overlapping Holdings
Symbol | Grade | Weight in GRPM | Weight in CNCR | Overlap |
---|
GRPM Underweight 68 Positions Relative to CNCR
Symbol | Grade | Weight | |
---|---|---|---|
GERN | B | -3.67% | |
ELVN | C | -3.15% | |
SMMT | B | -3.11% | |
ACRV | C | -2.35% | |
NUVB | B | -2.24% | |
ITOS | B | -2.21% | |
ERAS | C | -2.14% | |
NRIX | C | -2.07% | |
RVMD | B | -1.97% | |
AURA | B | -1.83% | |
BPMC | C | -1.72% | |
MRUS | D | -1.7% | |
PRLD | C | -1.67% | |
TSVT | C | -1.66% | |
CGEM | D | -1.57% | |
TYRA | B | -1.57% | |
REPL | C | -1.56% | |
FHTX | C | -1.55% | |
PGEN | C | -1.55% | |
REGN | A | -1.54% | |
IGMS | C | -1.53% | |
JANX | D | -1.51% | |
KYMR | B | -1.51% | |
HCM | C | -1.49% | |
DAWN | C | -1.48% | |
STRO | D | -1.46% | |
MRK | F | -1.45% | |
BCYC | B | -1.42% | |
EXEL | A | -1.4% | |
RLAY | D | -1.38% | |
IMTX | C | -1.38% | |
SNDX | C | -1.33% | |
XNCR | F | -1.31% | |
KURA | D | -1.3% | |
GMAB | C | -1.29% | |
IDYA | B | -1.29% | |
BNTX | F | -1.28% | |
BMY | B | -1.28% | |
NUVL | C | -1.28% | |
ACLX | C | -1.22% | |
RCUS | D | -1.19% | |
SDGR | C | -1.18% | |
LEGN | C | -1.17% | |
IPHA | D | -1.14% | |
YMAB | D | -1.11% | |
AUTL | C | -1.11% | |
ACET | C | -1.09% | |
RPTX | F | -1.05% | |
KPTI | F | -1.05% | |
RXRX | F | -1.04% | |
GLUE | D | -1.03% | |
SWTX | F | -1.02% | |
FATE | C | -1.02% | |
LYEL | F | -0.97% | |
ALLO | D | -0.91% | |
IMCR | F | -0.9% | |
IOVA | D | -0.87% | |
ARVN | D | -0.85% | |
VOR | F | -0.72% | |
CRBU | D | -0.6% | |
IMRX | D | -0.6% | |
MRSN | F | -0.56% | |
RAPT | F | -0.53% | |
GNLX | F | -0.48% | |
MGNX | F | -0.47% | |
DNA | F | -0.47% | |
BMEA | F | -0.45% | |
ZNTL | F | -0.4% |
GRPM: Top Represented Industries & Keywords
Industries:
Oil & Gas E&P
Auto & Truck Dealerships
Banks - Regional - US
Beverages - Soft Drinks
Biotechnology
Diagnostics & Research
Footwear & Accessories
Oil & Gas Drilling
Keywords:
Natural Gas
Abdominal Pain
Acetate
Antibodies
Artery
Artery Disease
Atopic Dermatitis
Autoimmune Disease
Automobile Repair Shop
Automotive Finance
Automotive Products
Automotive Retail
Automotive Retailer
Bank
Biopharmaceutical
Biotechnology
Bone
Car Dealership
Cardiovascular And Other Diseases
Chemical Elements
CNCR: Top Represented Industries & Keywords